Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism

Clinical Endocrinology

Volumn 63, Issue 5, 2005, Pages 582-587

  Hueston, William J ^a   King, Dana E ^a   Geesey, Mark E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE; HYPOCHOLESTEROLEMIC AGENT; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; HUMAN; HYPOTHYROIDISM; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPOTHYROIDISM; INFLAMMATION; LINEAR MODELS; MALE; MIDDLE AGED; THYROTROPIN; THYROXINE;

EID: 27744523557     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02388.x     Document Type: Article

References (37)

1. Franklyn, J. (1995) Subclinical hypothryoidism. Clinical Endocrinology, 43, 443-444.
2. Sawin, C.T., Castelli, W.P., Hershman, J.M., McNamara, P. & Bacharach, P. (1985) The ageing thyroid: thyroid deficiency in the Framingham study. Archives of Internal Medicine, 145, 1386-1388.
3. Tunbridge, W.M.G., Evered, D.C., Hall, R., Appleton, D., Brewis, M., Clark, F., Evans, J.G., Young, E., Bird, T. & Smith, P.A. (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology, 7, 481-483.
4. Canaris, G.K., Manowitz, N.R., Mayor, G.M. & Ridgway, E.C. (2000) The Colorado thyroid disease prevalence study. Archives of Internal Medicine, 160, 526-534.
5. Jaeschke, R., Guyatt, G., Gerstein, H., Patterson, C., Molloy, W., Cook, D., Harper, S., Griffith, L. & Carbotte, R. (1996) Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? Journal of General Internal Medicine, 11,744-749.
6. Cooper, D.S., Halpern, R., Wood, L.C., Levin, A.A. & Ridgway, E.G. (1984) L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Annals of Internal Medicine, 101, 18-24.
7. Cooper, D.S. (1998) Subclinical thyroid disease: a clinician's perspective. Annals of Internal Medicine, 129, 135-137.
8. American College of Physicians (1998) Screening for thyroid disease. Annals of Internal Medicine, 129, 141-143.
9. U.S. Preventive Services Task Force (1996) Guide to Clinical Preventive Services: Report of the U. S. Preventive Services Task Force, 2nd edn. International Medical Publishing, Alexandria, VA.
10. Bemben, D.A., Hamm, R.M., Morgan, L., Winn, P., Davis, A. & Barton, E. (1994) Thyroid disease in the elderly. Part 2. Predictability of subclinical hypothyroidism. Journal of Family Practice, 38, 583-588.
11. Biondi, B. & Klein, I. (2004) Hypothyroidism as a risk for cardiovascular disease. Endocrine, 24, 1-23.
12. Vanderpump, M.P., Tunbridge, W.M.G., French, J.M., Appleton, D., Bates, D., Clark, F., Grimley Evans, J., Rodgers, H., Tunbridge, F. & Young, E.T. (1996) The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-study of an English community. Thyroid, 6, 155-160.
13. Hak, A.E., Pols, H.A.P., Visser, T.J., Drexhage, H.A., Hofman, A. & Witteman, J.C.M. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of Internal Medicine, 132, 270-278.
14. Imaizumi, M., Akahoski, M., Ichimaru, S., Nakashima, E., Hida, A., Soda, M., Usa, T., Ashizawa, K., Yokoyama, N., Maeda, R., Nagataki, S. & Eguchi, K. (2004) Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 89, 3365-3370.
15. Biondi, B., Palmieri, E.A., Lombardi, G. & Fazio, S. (2002) Effects of subclinical thyroid dysfunction on the heart. Annals of Internal Medicine, 137, 904-914.
16. Surks, M.I., Ortiz, E., Daniels, G.H., Sawin, C.T., Col, N.F., Cobin, R.H., Franklyn, J.A., Hershman, J.M., Burman, K.D., Denke, M.A., Gorman, C., Cooper, R.S. & Weissman, N.J. (2004) Subclinical thyroid disease. Scientific review and guidelines for diagnosis and treatment. Journal of the American Medical Association, 291, 228-238.
17. Gharib, H., Tuttle, R.M., Baskin, H.J., Fish, L.H., Singer, P.A. & McDermott, M.T. (2005) Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Clinical Endocrinology and Metabolism, 90, 581-585.
18. Abdelmouttaleb, I., Danchin, N., Ilardo, C., Aimone-Gastin, I., Angioi, M., Lozniewski, A., Loubinoux, J., Le Faou, A. & Gueant, J.L. (1999) C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. American Heart Journal, 137, 346-351.
19. Ridker, P.M., Glynn, R.J. & Hennekens, C.H. (1998) C-reactive protein adds to the predictive value of total and HDE cholesterol in determining risk of first myocardial infarction. Circulation, 97, 2007-2011.
20. Ridker, P.M., Rifai, N., Rose, L., Buring, J.E. & Cook, N.R. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347, 1557-1565.
21. Pahor, M., Elam, M.B., Garrison, R.J., Kritchevsky, S.B. & Applegate, W.B. (1999) Emerging noninvasive biochemical measures to predict cardiovascular risk. Archives of Internal Medicine, 159, 237-245.
22. Bostom, A.G., Silbershatz, H., Rosenberg, I.H., Selhub, J., D'Agostino, R.B., Wolf, P.A., Jacques, P.F. & Wilson, P.W. (1999) Nonfasting plasma total homocysteine levels and all-cause cardiovascular disease mortality in elderly Framingham men and women. Archives of Internal Medicine, 159, 1077-1080.
23. National Center for Health Statistics, NHANES website: http:// www.cdc.gov/nchs/nhanes.htm, accessed May 2005.
24. Libby, P. & Ridker, P.M. (1999) Novel inflammatory markers of coronary risk: theory versus practice. Circulation, 100, 1148-1150.
25. Graham, I.M., Daly, L., Refsum, H., Robinson, K., Brattström, L.E., Ueland, P.M., Palma-Reis, R.J., Boers, G.H., Sheahan, R.G., Israelsson, B., Uiterwaal, C.S., Meleady, R., McMaster, D., Verhoef, P., Witteman, J., Rubba, P., Bellet, H., Wautrecht, J.C., de Valk, H.W., Sales Luis, A.C., Parrot-Rouland, F.M., Tan, K.S., Higgins, I., Garcon, D. & Andria, G. (1997) Plasma homocysteine as a risk factor for vascular disease. Journal of the American Medical Association, 277, 1775-1781.
26. Deicher, R. & Vierhapper, H. (2002) Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid, 12, 733-736.
27. Luboshitzky, R., Aviv, A., Herer, P. & Lavie, L. (2002) Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid, 12,421-425.
28. Sengul, E., Cetinarsian, B., Tarkun, I., Canturk, Z. & Turemen, E. (2004) Homocysteine concentrations in subclinical hypothyroidism. Endocrine Research, 30, 351-359.
29. Christ-Grain, M., Meier, C., Gulielmetti, M., Huber, R.P., Riesen, W., Staub, J.J. & Muller, B. (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and double-blind, placebo-controlled trial. Atherosclerosis, 166, 379-386.
30. Tracy, R.P., Psaty, B.M., Macy, E., Bovill, E.G., Cushman, M., Cornell, E.S. & Kuller, L.H. (1997) Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2167-2176.
31. Nygard, O., Refsum, H., Ueland, P.M. & Vollset, S.E. (1998) Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition, 67, 263-270.
32. Sutton-Tyrrell, K., Bostom, A., Selhub, J. & Zeigler-Johnson, C. (1997) High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation, 96, 1745-1749.
33. Ford, E. (1999) Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care, 22, 1971-1977.
34. Ridker, P.M., Hennekens, C.H., Rifai, N., Buring, J.E. & Manson, J.E. (1999) Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation, 100, 713-716.
35. Ridker, P.M., Buring, J.E., Shih, J., Matias, M. & Hennekens, C.H. (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among healthy women. Circulation, 98, 731-733.
36. Morris, M.S., Bostom, A.G., Jacques, P.F., Selhub, J. & Rosenberg, J.H. (2001) Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis, 155, 195-200.
37. Wells, B.J. & Hueston, W.J. (2005) Are thyroid peroxidase antibodies associated with cardiovascular disease risk in patients with subclinical hypothyroidism. Clinical Endocrinology, 62, 580-584.